New Jersey-based pharmaceutical manufacturer agrees to pay over $2 million to settle allegations
U.S. Attorney Philip Sellinger announced the deal settles allegations Novel Laboratories violated the Controlled Substances Act.
•
Apr 11, 2024, 11:28 AM
•
Updated 287 days ago
Share:
More Stories
0:21
Authorities identify woman whose body was found in Neptune retention basin
19h ago1:26
How to maintain your car in the brutal cold
2ds ago1:50
be Well: Benefits of bariatric surgery
2ds ago1:47
How are sweets, carbs and red meat affecting your brain?
4ds ago1:29
What you should know about Red 3, now banned from nation’s food supply
5ds ago0:19
Flemington boil water advisory remains in effect following water main break
5ds ago0:21
Authorities identify woman whose body was found in Neptune retention basin
19h ago1:26
How to maintain your car in the brutal cold
2ds ago1:50
be Well: Benefits of bariatric surgery
2ds ago1:47
How are sweets, carbs and red meat affecting your brain?
4ds ago1:29
What you should know about Red 3, now banned from nation’s food supply
5ds ago0:19
Flemington boil water advisory remains in effect following water main break
5ds agoA drug manufacturer based in Somerset has agreed to pay $2.25 million to the federal government.
U.S. Attorney Philip Sellinger announced Wednesday that the deal settles allegations Novel Laboratories violated the Controlled Substances Act.
Officials say a Drug Enforcement Administration investigation revealed that Novel Laboratories failed to account for large amounts of oxycodone, hydrocodone and temazepam over a two-year period beginning in 2019.
More from News 12
1:26
Mariano Rivera's lawyer denies knowledge, cover-up of child abuse claims in lawsuit
0:25
Atlantic City mayor seeks reelection despite abuse allegations
0:25
New York Ferry offers $3 rides for PATH users during Hoboken Station closure
1:44
Crews work to repair multiple water main breaks around New Jersey
1:53
Fire in Jersey City destroys at least 2 businesses and apartments
1:11
